Simulation studies in autosomal recessive cerebellar ataxia show that longitudinal non-linear mixed-effects modelling improves power and controls type I error compared with standard analyses, enabling more efficient trial designs—particularly parallel and delayed-start designs—in rare diseases with small, heterogeneous cohorts.
